Pulmonary & Arterial hypertension

Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. The most relevant mechanisms for sudden cardiac death in PAH patients seem to be related to severe dilatation of the pulmonary artery, as subsequent complications, such as left main compression syndrome, pulmonary artery dissection, pulmonary artery rupture, and massive hemoptysis, may take place.An arterial high blood pressure has the characteristic of pressure indicators, either equal of higher than 140 mm Hg for the systolic or 90 mm Hg for the diastolic pressure, after having repeatedly measured the arterial tension. Essential arterial hypertension is one of the main treatable cardiovascular risk factors. It can be well controlled and the cardiovascular risk reduced through a combination of lifestyle interventions and first-line antihypertensive drugs.

    Related Conference of Pulmonary & Arterial hypertension

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland

    Pulmonary & Arterial hypertension Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in